Immunology Strategic Roundup: Expansion Meets Safety | Aug 18 - Sept 22, 2026
Immunology Market Trends: Expansion, Durability, Safety and Smarter Discovery…
Immunology Strategic Roundup | July 14 - August 18, 2026
Immunology Strategic Roundup exploring Key Strategic Developments and…
Cell and Gene Therapy Today—June 11, 2026
This week’s Gene and Cell Therapy update highlights regulatory advances,…
Nurix Roche Bexobrutideg Deal | Lucid Diligence Brief
Roche’s collaboration with Nurix turns bexobrutideg into a multi-indication BTK…
Hematology Today—May 11, 2026
This week’s Hematology update highlights clinical financing activity, precision…
Lucid Diligence Brief: UCB acquisition of Candid Therapeutics
Lucid Diligence Brief: UCB acquisition of Candid Therapeutics Professional…
Lucid Diligence Brief: Beeline Medicines debuts with $300M Series A
Lucid Diligence Brief: Beeline Medicines debuts with $300M Series A…
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B…
Women’s Health Today—April 1, 2026
This biweekly Women’s Health video recap highlights regulatory progress,…
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines Professional…